This inventor holds 2 USPTO granted patents. Top assignee: Becton Dickinson and Company Limited. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: The Innovations of Dorothy T Steimel-Crespi
Introduction
Dorothy T Steimel-Crespi is a notable inventor based in Marblehead, MA (US). She has made significant contributions to the field of biochemistry, particularly in the study of P-glycoproteins. With a total of 2 patents, her work has implications for drug bioavailability and the development of inhibitors.
Latest Patents
Her latest patents include groundbreaking inventions related to P-glycoproteins in both dogs and cynomologous monkeys. The first patent pertains to dog P-glycoproteins, which includes dog-specific amino acids and nucleic acids encoding these polypeptides. This invention also covers fragments and biologically functional variants of the dog P-glycoprotein. Furthermore, it relates to methods for determining the bioavailability of drugs and screening for inhibitors of dog PGP. The second patent focuses on cynomologous monkey P-glycoproteins, similarly including cynomologous-specific amino acids and nucleic acids. This invention also encompasses fragments and variants of the cynomologous monkey P-glycoprotein, along with methods for drug bioavailability and screening for inhibitors.
Career Highlights
Dorothy T Steimel-Crespi is currently employed at Becton Dickinson and Company Limited, where she continues to advance her research in biochemistry. Her work has been instrumental in understanding the role of P-glycoproteins in pharmacology.
Collaborations
Some of her notable coworkers include Penny J Stocker and Charles L Crespi, who have collaborated with her on various projects related to her patents.
Conclusion
Dorothy T Steimel-Crespi's contributions to the field of biochemistry through her patents on P-glycoproteins highlight her innovative spirit and dedication to advancing medical science. Her work continues to influence the understanding of drug interactions and bioavailability.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
